<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02558478</url>
  </required_header>
  <id_info>
    <org_study_id>5885</org_study_id>
    <nct_id>NCT02558478</nct_id>
  </id_info>
  <brief_title>Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing</brief_title>
  <acronym>GEN-NEUROSENS</acronym>
  <official_title>Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Next Generation Sequencing (NGS) strategy is a powerful tool to identify genes implicated in
      very rare diseases for which the previous genetic explorations remain negative to date. The
      aim of this project is based on groups of patients with original clinical phenotypes
      including neurosensory impairment without genetic cause identified to date. The investigators
      will study these families using whole exome sequencing to potentially identify new genes and
      new underlying biological pathways involved in neurosensory diseases.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Whole exome sequencing data</measure>
    <time_frame>21 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">39</enrollment>
  <condition>Neurosensory Diseases</condition>
  <condition>Retinopathy</condition>
  <condition>Hearing Loss</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>blood sampling</intervention_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA Fibroblasts
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This project focuses on families with unsual phenotypes who have sensorineural disease with
        retinal degeneration AND/OR deafness. Our first hypothesis is that these clinical entities
        are associated with new genes not described to date. However, it is impossible to exclude
        at this stage an allelic variability (mutations in genes already known but with an unusual
        phenotype) or mutations in genes implicated in neurosensory diseases but not detected by
        prior exploration. These situations illustrate the problem of genetic complexity and
        difficulty of the phenotype correlations - genotype.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Original phenotype with neurosensory diseases

          -  Written, informed consent obtained

        Exclusion Criteria:

          -  Refusal to participate at the study

          -  Prior inclusion in a similar study (NGS)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sophie SCHEIDECKER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sophie SCHEIDECKER, MD</last_name>
    <phone>33.3.88.12.73.33</phone>
    <email>SOPHIE.scheidecker@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean MULLER, PHD</last_name>
    <phone>33.3.69.55.11.66</phone>
    <email>jean.muller@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>LABORATOIRE DE CYTOGENETIQUE, Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie SCHEIDECKER, MD</last_name>
      <phone>33.3.88.12.73.33</phone>
      <email>sophie.scheidecker@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Sophie SCHEIDECKER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hélène DOLLFUS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yaumara PERDOMO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elise SCHAEFER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2015</study_first_submitted>
  <study_first_submitted_qc>September 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2015</study_first_posted>
  <last_update_submitted>December 6, 2016</last_update_submitted>
  <last_update_submitted_qc>December 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Whole exome sequencing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

